Beijersbergen van Henegouwen G M
Center for Bio-Pharmaceutical Sciences, University of Leiden, The Netherlands.
J Photochem Photobiol B. 1991 Aug;10(3):183-210. doi: 10.1016/1011-1344(91)85002-x.
Xenobiotics extensively used in drugs, cosmetics, food and agricultural chemicals can produce adverse biological effects. These toxic effects are separated into classes, e.g. hepatotoxicity, genotoxicity and neurotoxicity. Skin allergy, part of immunotoxicity, is also a subdivision of toxicology. When light is an essential condition for toxicity, the xenobiotic is called phototoxic. Thus it fits into the logic of toxicology that photoallergic compounds are a subdivision of phototoxic compounds. Phototoxicons as a group do not differ from the group of phototherapeutics with regard to their eventual biological effects. The primary photoreactions, secondary molecular processes, biomolecules involved and cellular and tissue damage are similar. The difference between the two groups is in the appreciation of the photobiological effects: adverse vs. desired. The aim of research is to determine the part of the molecular structure which makes a given compound phototoxic. With that knowledge the structure of the phototoxicon can be changed. This can result in a derivative which still has the desired properties of the parent compound, but is no longer phototoxic. This aim can be reached by combining data from both in vitro and in vivo research. The variety and number of phototoxic compounds is large. This, together with the limited research effort devoted to this subject so far, means that for most phototoxic xenobiotics a relationship between structure and in vivo photoreactivity is not available. In this review, emphasis is placed on xenobiotics whose in vitro and in vivo photochemistry have been studied. Furthermore, possible phototoxic effects which do not concern the skin but involve inner organs (systemic effects) are considered. References in this review mostly concern investigations over the last 10 years. For older literature or for additional information, references to other reviews are given. Important groups of phototoxic xenobiotics not dealt with in this article were already sufficiently covered in the reviews referred to.
广泛用于药品、化妆品、食品和农用化学品中的外源化学物质可产生不良生物学效应。这些毒性效应可分为不同类别,例如肝毒性、遗传毒性和神经毒性。皮肤过敏作为免疫毒性的一部分,也是毒理学的一个细分领域。当光照是毒性产生的必要条件时,这种外源化学物质就被称为光毒性物质。因此,光过敏化合物作为光毒性化合物的一个细分领域符合毒理学的逻辑。光毒性物质作为一个群体,在其最终生物学效应方面与光治疗剂群体并无不同。初级光反应、次级分子过程、涉及的生物分子以及细胞和组织损伤都是相似的。这两个群体的区别在于对光生物学效应的认识:不良效应与期望效应。研究的目的是确定给定化合物产生光毒性的分子结构部分。有了这些知识,就可以改变光毒性物质的结构。这可能会产生一种衍生物,它仍然具有母体化合物的期望特性,但不再具有光毒性。通过结合体外和体内研究的数据可以实现这一目标。光毒性化合物的种类和数量众多。这一点,再加上迄今为止针对该主题的研究工作有限,意味着对于大多数光毒性外源化学物质而言,结构与体内光反应性之间的关系尚不明确。在本综述中,重点关注了其体外和体内光化学已得到研究的外源化学物质。此外,还考虑了可能不涉及皮肤但涉及内部器官的光毒性效应(全身效应)。本综述中的参考文献大多涉及过去10年的研究。对于更早的文献或获取更多信息,会给出其他综述的参考文献。本文未涉及的重要光毒性外源化学物质组在相关综述中已有充分涵盖。